GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference

Rhea-AI Summary

GeneDx (Nasdaq: WGS) announced participation in the Cowen 43rd Annual Healthcare Conference on March 7, 2023, in Boston, MA. CEO Katherine Stueland will engage in a fireside chat at 2:50 p.m. ET. The event is expected to highlight the company’s advancements in genomic and clinical insights aimed at enhancing health outcomes.

A live and archived webcast of the discussion will be accessible through the 'Events' section of the GeneDx investor relations website. GeneDx specializes in precision medicine, utilizing genomic data to improve diagnosis and treatment options. For further information, visit the GeneDx website.

STAMFORD, Conn., March 01, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate at the Cowen 43^rd Annual Healthcare Conference in Boston, MA. Katherine Stueland, President and Chief Executive Officer, will participate in a fireside chat on Tuesday, March 7, 2023, at 2:50 p.m. ET.

A live and archived webcast of the presentation will be available on the “Events” section of the GeneDx investor relations website at ir.genedx.com/news-events/events.

About GeneDx

GeneDx, (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets.

For more information, please visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.

Investor contact
Tricia Truehart
Investors@GeneDx.com

Media contact
Stephanie Kahan
Press@GeneDx.com

FAQ

When is the GeneDx presentation at the Cowen 43rd Annual Healthcare Conference?

The GeneDx presentation will occur on March 7, 2023, at 2:50 p.m. ET.

Where can I watch the GeneDx conference webcast?

The webcast will be available in the 'Events' section of the GeneDx investor relations website.

Who is speaking at the GeneDx fireside chat?

Katherine Stueland, the CEO of GeneDx, will participate in the fireside chat.

What is the focus of GeneDx's presentation at the conference?

The presentation will emphasize GeneDx's genomic and clinical insights aimed at improving health outcomes.

What is GeneDx's stock symbol?

The stock symbol for GeneDx is WGS.